Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24905687 | 0.91 | HDAC6 (0.41) | HDAC6MAOABCHEACHEMEN1 | |
| SCHEMBL21868262 | 0.90 | HDAC6 (0.40) | HDAC6MAOABCHEACHEMEN1 | |
| SCHEMBL15183545 | 0.85 | HDAC6 (0.41) | HDAC6MAOABCHEACHEMEN1 | |
| SCHEMBL21688338 | 0.85 | HDAC6 (0.41) | HDAC6MAOABCHEACHEMEN1 | |
| SCHEMBL14550896 | 0.84 | HDAC6 (0.34) | HDAC6 | |
| SCHEMBL17929475 | 0.84 | PGR (0.32) | MEN1KMT2A | |
| SCHEMBL17929493 | 0.81 | — | — | |
| SCHEMBL13781069 | 0.81 | HDAC6 (0.46) | HDAC6BCHEACHEL3MBTL1NOX1 | |
| SCHEMBL14823501 | 0.81 | HDAC6 (0.44) | HDAC6MAOABCHEACHEMEN1 | |
| SCHEMBL19759958 | 0.81 | HDAC6 (0.34) | HDAC6MEN1ADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160211456-A1 | PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF | LUMINESCENCE TECHNOLOGY CORP. | 2016-07-21 | — | — | US | disclosed |
| US-20160211456-A1 | PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF | LUMINESCENCE TECHNOLOGY CORP. | 2016-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160211456-A1 | PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF | POP1, TERB1, AP2B1 | HDAC6 4572/4885MAOA 3575/4885BCHE 4234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.